General Information
Drug ID
DR00077
Drug Name
Brilinta
Synonyms
AR-C126532; AZD-6140; Brilique; Ticagrelor; Ticagrelor (USAN/INN)
Drug Type
Small molecular drug
Indication Thrombosis [ICD11:BD71.4, BD72] Approved [1]
Structure
3D MOL 2D MOL
Formula
C23H28F2N6O4S
Canonical SMILES
CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F
InChI
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
InChIKey
OEKWJQXRCDYSHL-FNOIDJSQSA-N
CAS Number
CAS 274693-27-5
Pharmaceutical Properties Molecular Weight 522.6 Topological Polar Surface Area 164
Heavy Atom Count 36 Rotatable Bond Count 10
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 12
XLogP
2
PubChem CID
9871419
PubChem SID
103554312 ,123051091 ,124759706 ,126644885 ,126666051 ,135649975 ,136345665 ,137171656 ,139857160 ,14836432 ,14860737 ,152040158 ,152258075 ,160645837 ,160646914 ,162011636 ,163346229 ,163383616 ,164178089 ,164765598 ,165245536 ,170501033 ,171063069 ,172914585 ,174528632 ,175267325 ,175427101 ,185974765 ,189657701 ,198993342 ,211534943 ,223384813 ,223666650 ,224638556 ,228139491 ,24162024 ,247988848 ,249582784 ,249807649 ,249807650 ,249816423 ,251966736 ,251970939 ,252216468 ,45293678 ,49684205 ,57373617 ,77877844 ,92729712 ,96025700
ChEBI ID
CHEBI:68558
TTD Drug ID
D0WF7L
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Brilinta was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665)

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.